<DOC>
	<DOCNO>NCT00631033</DOCNO>
	<brief_summary>The purpose study determine whether additive effect metformine weight reduction obese hyperinsulinemic men treat diazoxide .</brief_summary>
	<brief_title>DZX Mediated Insulin Suppression Obese Men</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<criteria>male age 2550 year BMI 3035 kg/m2 stable body weight 3 month start study glucose &lt; = 6.0 mmol/L Cpeptide &gt; = 1.0 nmol/L HbA1c &lt; = 6.0 % comorbidity medication serum creatinine &gt; 120 micromol/L liver enzymes &gt; 2 time upper limit normal gout alcohol use &gt; 2 alcoholic drink day drug abuse cessation smoking le 6 month ago</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>obesity</keyword>
	<keyword>hyperinsulinism</keyword>
	<keyword>diazoxide</keyword>
	<keyword>metformin</keyword>
</DOC>